4.4 Review

Cognitive, neuropsychiatric and neurological alterations in mastocytosis: A systematic review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Psychology, Clinical

Depression, psychosocial correlates, and psychosocial resources in individuals with mast cell activation syndrome

Jennifer Nicoloro SantaBarbara et al.

Summary: Individuals with Mast Cell Activation Syndrome (MCAS) often experience significant levels of depression, especially among younger participants and those who report greater loneliness or more disease-specific stressors. The severity of depressive symptoms is associated with greater illness intrusiveness, less social support, and lower optimism. Interventions targeting loneliness and unique stressors in this population are valuable.

JOURNAL OF HEALTH PSYCHOLOGY (2022)

Article Medicine, General & Internal

A case of systemic mastocytosis mimicking POEMS syndrome A case report

Yanqiu Hou et al.

Summary: This article reports a case of systemic mastocytosis (SM) that was misdiagnosed as POEMS syndrome, and analyzes the differences between the two diseases to aid in accurate diagnosis and differentiation.

MEDICINE (2022)

Review Behavioral Sciences

Global prevalence of autism: A systematic review update

Jinan Zeidan et al.

Summary: This article reviews the prevalence of autism worldwide, considering the impact of geographic, ethnic, and socioeconomic factors on prevalence estimates. Approximately 1/100 children are diagnosed with autism spectrum disorder around the world. Prevalence estimates increased over time and varied greatly within and across sociodemographic groups. These findings reflect changes in the definition of autism and differences in the methodology and contexts of prevalence studies.

AUTISM RESEARCH (2022)

Article Allergy

Impact of mental health on disease activity in mastocytosis during COVID-19 pandemic

Nida Oztop et al.

Summary: This study investigated the influence of mental health problems developed during the COVID-19 pandemic on the course of mastocytosis. The study found that fear of COVID-19 and mental health status were more severe in patients during the lockdown period (LP) compared to the return to normal period (RTNP), and there was a positive correlation between mental health status and exacerbation of mastocytosis symptoms. Therefore, providing psychological support during the pandemic is important in controlling the severity of mastocytosis symptoms.

ALLERGOLOGY INTERNATIONAL (2022)

Article Oncology

Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider Survey

Ruben A. Mesa et al.

Summary: This study examined the perceptions and management strategies of US health care providers treating systemic mastocytosis (SM). Most patients were found to have nonadvanced disease, but symptoms significantly disrupted their lives. Physicians estimated that SM is diagnosed within months of symptom onset, contrary to previous reports of longer delays.

CANCER (2022)

Article Allergy

The role of the clinical and psychological symptoms of mastocytosis in the patient?s quality of life

Natalia Spolak-Bobryk et al.

Summary: This study assessed the clinical and psychological symptoms, quality of life, and satisfaction with life in patients with mastocytosis. The results showed that allergy symptoms were associated with lower quality of life in leisure time. Anxiety, depression, and irritability were positively correlated with general quality of life, while satisfaction with current life and life in the next 4 weeks were negatively correlated. The findings highlight the importance of improving patients' quality of life.

POSTEPY DERMATOLOGII I ALERGOLOGII (2022)

Article Allergy

Olfactory Function Is Impaired in Patients with Mastocytosis

Carla Masala et al.

Summary: Patients with systemic mastocytosis showed impaired olfactory function compared with healthy controls. A significant negative correlation was found between olfactory function and serum tryptase concentration. Olfactory dysfunction may be considered as a clinical manifestation contributing to the burden of mastocytosis.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Hematology

Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management

Animesh Pardanani

Summary: Systemic mastocytosis (SM) is a disease caused by the clonal proliferation of abnormal mast cells in extra-cutaneous organs, diagnosed primarily based on the presence of abnormal mast cells in the bone marrow. Risk stratification is important for treatment planning, with options including small-molecule inhibitors targeting mutant-KIT for advanced cases. Treatment goals involve symptom control and prevention of complications such as anaphylaxis in indolent cases, while cytoreductive therapy may be necessary for those with advanced disease.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Allergy

Impaired endothelial function irrespective of systemic inflammation or atherosclerosis in mastocytosis

Nida Oztop et al.

Summary: In patients with mastocytosis, endothelial dysfunction is evident with decreased flow-mediated dilatation (FMD) and elevated serum vascular endothelial growth factor (VEGF) levels, without the presence of atherosclerosis or systemic inflammation. The severity of the disease is related to the changes in FMD and VEGF levels.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)

Article

Executive Dysfunction and the Prefrontal Cortex

David T. Jones et al.

CONTINUUM Lifelong Learning in Neurology (2021)

Article Allergy

Health-Related Quality of Life and Influencing Factors in Adults with Nonadvanced Mastocytosis-A Cross-Sectional Study and Qualitative Approach

Stephanie Pulfer et al.

Summary: Mastocytosis patients commonly experience impairments in quality of life and psychological burden, with some patients experiencing severe impairments related to symptoms. Factors such as age, body mass index, tryptase level, duration of symptoms, and current drug therapy are associated with HRQOL.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Allergy

Assessing quality of life in patients with mastocytosis: development of the disease-specific questionnaire

Natalia Spolak-Bobryk et al.

Summary: This study developed a questionnaire to measure the quality of life in patients with mastocytosis, taking into account the specific difficulties experienced by these patients, providing a tool for psychoeducation and precise diagnosis of their quality of life.

POSTEPY DERMATOLOGII I ALERGOLOGII (2021)

Letter Allergy

Neurocognitive dysfunction and anaphylaxis in pediatric maculopapular cutaneous mastocytosis

Emily A. Gurnee et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

Article Dermatology

Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study

M. Fradet et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Letter Allergy

Neuroinflammatory disorders and mastocytosis: A possible association?

Francois Rodrigues et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Review Pharmacology & Pharmacy

An evaluation of masitinib for treating systemic mastocytosis

Mariarita Laforgia et al.

EXPERT OPINION ON PHARMACOTHERAPY (2019)

Article Psychology, Clinical

Psychosocial impact of mast cell disorders: Pilot investigation of a rare and understudied disease

Jennifer Nicoloro-SantaBarbara et al.

JOURNAL OF HEALTH PSYCHOLOGY (2017)

Article Medicine, General & Internal

Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre

Maud A. W. Hermans et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)

Letter Dermatology

Exploring the prevalence of learning disabilities in children with cutaneous mastocytosis: A pilot cohort study

Alexandra Seamens et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)

Review Neurosciences

Brain fog, inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin

Theoharis C. Theoharides et al.

FRONTIERS IN NEUROSCIENCE (2015)

Article Immunology

Leukocyte telomere length in mastocytosis: Correlations with depression and perceived stress

Sophie Georgin-Lavialle et al.

BRAIN BEHAVIOR AND IMMUNITY (2014)

Article Clinical Neurology

Primary headache syndromes in systemic mastocytosis

Jonathan H. Smith et al.

CEPHALALGIA (2011)

Article Clinical Neurology

Neurologic symptoms and diagnosis in adults with mast cell disease

Jonathan H. Smith et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2011)

Article Multidisciplinary Sciences

Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy

Daniela Silva Moura et al.

PLOS ONE (2011)

Article Anesthesiology

Psychological treatments for fibromyalgia: A meta-analysis

Julia A. Glombiewski et al.

Editorial Material Immunology

AUTISM SPECTRUM DISORDERS AND MASTOCYTOSIS

Theoharis C. Theoharides

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)

Article Immunology

Mast cell transcripts are increased within and outside multiple sclerosis lesions

Nicolas Couturier et al.

JOURNAL OF NEUROIMMUNOLOGY (2008)

Article Multidisciplinary Sciences

Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis

Olivier Hermine et al.

PLOS ONE (2008)

Article Pharmacology & Pharmacy

Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress

P Esposito et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)